IP Library Assignment 065017/0488
Patent Assignment
Reel/Frame 065017/0488

Change of Name

Recorded: 2023-09-21 Pages: 6
Assignor
KALA PHARMACEUTICALS, INC.
Executed: 2023-08-02
Assignee
KALA BIO, INC.
1167 MASSACHUSETTS AVENUE, ARLINGTON, MASSACHUSETTS, 02476
Covered Properties (45)
Therapeutic Compounds and Uses Thereof
Patent: 9,353,122 →
Application: 14/181,095 →
Publication: US 2014/0235634
Therapeutic Compounds and Uses Thereof
Patent: 9,353,123 →
Application: 14/184,886 →
Publication: US 2014/0235657
Urea Derivatives and Uses Thereof
Patent: 9,212,145 →
Application: 14/301,653 →
Publication: US 2015/0072986
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Patent: 9,458,169 →
Application: 14/530,092 →
Publication: US 2015/0125535
Therapeutic Compounds and Uses Thereof
Patent: 9,695,184 →
Application: 14/768,038 →
Publication: US 2016/0002254
Compounds for Treatment of Diseases of Abnormal Angiogenesis or Aberrant Growth Factors and Uses Thereof
Patent: 9,988,386 →
Application: 14/894,214 →
Publication: US 2016/0137646
Urea Derivatives and Uses Thereof
Patent: 9,580,421 →
Application: 14/939,727 →
Publication: US 2016/0060264
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Patent: 9,790,232 →
Application: 14/981,105 →
Publication: US 2016/0115176
Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
Patent: 9,688,688 →
Application: 15/032,595 →
Publication: US 2016/0257693
Therapeutic Compounds and Uses Thereof
Patent: 9,827,248 →
Application: 15/139,099 →
Publication: US 2016/0235761
Therapeutic Compounds and Uses Thereof
Patent: 9,877,970 →
Application: 15/139,107 →
Publication: US 2016/0237093
Therapeutic Compounds and Uses Thereof
Patent: 9,833,453 →
Application: 15/139,121 →
Publication: US 2016/0235753
Therapeutic Compounds and Uses Thereof
Patent: 9,861,634 →
Application: 15/139,135 →
Publication: US 2016/0237094
Urea Derivatives and Uses Thereof
Patent: 9,802,922 →
Application: 15/411,485 →
Publication: US 2017/0129876
Crystalline Forms of a Therapeutic Compound and Uses Thereof
Application: 15/529,969 →
Publication: US 2017/0313724
1-Amino-triazolo(1,5-A)pyridine-substituted Urea Derivative and Uses Thereof
Application: 15/534,448 →
Publication: US 2018/0057489
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Patent: 9,890,173 →
Application: 15/604,080 →
Publication: US 2017/0260193
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Application: 15/694,252 →
Publication: US 2018/0065977
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Application: 15/694,331 →
Publication: US 2018/0065978
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Application: 15/694,383 →
Publication: US 2018/0065979
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Application: 15/712,645 →
Publication: US 2018/0009824
Urea Derivatives and Uses Thereof
Application: 15/782,696 →
Publication: US 2018/0037572
Urea Derivatives and Uses Thereof
Application: 15/782,743 →
Publication: US 2018/0037573
Therapeutic Compounds and Uses Thereof
Application: 15/842,695 →
Publication: US 2018/0104246
Therapeutic Compounds and Uses Thereof
Application: 15/868,894 →
Publication: US 2018/0133225
Novel Compounds and Uses Thereof
Application: 15/970,740 →
Publication: US 2018/0251467
Novel Compounds and Uses Thereof
Application: 16/014,937 →
Publication: US 2019/0023710
Urea Derivatives and Uses Thereof
Application: 16/043,000 →
Publication: US 2018/0327389
Urea Derivatives and Uses Thereof
Application: 16/043,007 →
Publication: US 2018/0327390
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Application: 16/184,760 →
Publication: US 2019/0077810
1-Amino-triazolo(1,5-A)pyridine-substituted Urea Derivative and Uses Thereof
Application: 16/204,827 →
Publication: US 2019/0092772
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Application: 16/286,216 →
Publication: US 2019/0194218
Therapeutic Compounds and Uses Thereof
Application: 16/361,732 →
Publication: US 2019/0216812
Urea Derivatives and Uses Thereof
Application: 16/400,672 →
Publication: US 2019/0284172
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Application: 16/415,848 →
Publication: US 2019/0270752
Novel Compounds and Uses Thereof
Application: 16/422,606 →
Publication: US 2020/0157106
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Application: 16/513,505 →
Publication: US 2019/0337963
Therapeutic Compounds and Uses Thereof
Application: 16/522,550 →
Publication: US 2020/0054644
Biochemical binding of RET9 and VEGFR2 inhibitors
Application: 16/757,305 →
Publication: US 2021/0179582
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Application: 16/806,819 →
Publication: US 2020/0216459
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Application: 16/818,033 →
Publication: US 2020/0216460
Urea Derivatives and Uses Thereof
Application: 16/900,657 →
Publication: US 2020/0299272
Therapeutic Compounds and Uses Thereof
Application: 16/915,508 →
Publication: US 2020/0323854
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Application: 17/197,702 →
Publication: US 2021/0355133
Crystalline Forms of Therapeutic Compounds and Uses Thereof
Application: 17/315,080 →
Publication: US 2021/0261562
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 6, 2014
From: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 032829/0986 →
Assignment of Assignor's Interest May 6, 2014
From: ONG, WINSTON ZAPANTA; NOWAK, PAWEL WOJCIECH; KIM, JINSOO
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 032829/0862 →
Assignment of Assignor's Interest May 6, 2014
From: ASKEW, BEN C.
To: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
Reel/Frame 032829/0966 →
Assignment of Assignor's Interest May 9, 2014
From: ASKEW, BEN
To: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
Reel/Frame 032861/0868 →
Assignment of Assignor's Interest May 9, 2014
From: ONG, WINSTON ZAPANTA; NOWAK, PAWEL WOJCIECH; KIM, JINSOO
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 032861/0803 →
Assignment of Assignor's Interest May 9, 2014
From: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 032861/0976 →
Assignment of Assignor's Interest Aug 8, 2014
From: ONG, WINSTON ZAPANTA; NOWAK, PAWEL WOJCIECH; KIM, JINSOO; NGUYEN, MINH NGOC
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 033493/0135 →
Assignment of Assignor's Interest Nov 6, 2014
From: ENLOW, ELIZABETH; NGUYEN, MINH NGOC; ONG, WINSTON Z
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 034113/0739 →
Assignment of Assignor's Interest Sep 25, 2015
From: ONG, WINSTON Z.; NOWAK, PAWEL W.; KIM, JINSOO
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 036661/0915 →
Assignment of Assignor's Interest Sep 25, 2015
From: BREAKTROUGH CHEMISTRY ADVISORS, LLC
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 036662/0081 →
Assignment of Assignor's Interest Sep 25, 2015
From: ASKEW, BEN C.
To: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
Reel/Frame 036661/0974 →
Assignment of Assignor's Interest Dec 28, 2015
From: ENLOW, ELIZABETH; NGUYEN, MINH NGOC; ONG, WINSTON Z
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 037368/0668 →
Assignment of Assignor's Interest Jan 28, 2016
From: ASKEW, BEN C.; GOOD, ANDREW; ONG, WINSTON ZAPANTA; NOWAK, PAWEL WOJCIECH
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 037609/0089 →
Assignment of Assignor's Interest Mar 15, 2016
From: ONG, WINSTON ZAPANTA; NOWAK, PAWEL WOJCIECH; FEUTRILL, JOHN THOMAS; KIM, JINSOO
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 037980/0266 →
Assignment of Assignor's Interest Mar 15, 2016
From: ONG, WINSTON ZAPANTA; NOWAK, PAWEL WOJCIECH; FEUTRILL, JOHN THOMAS; KIM, JINSOO
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 037990/0294 →
Assignment of Assignor's Interest Apr 27, 2016
From: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 038398/0440 →
Assignment of Assignor's Interest Apr 27, 2016
From: ONG, WINSTON ZAPANTA; NOWAK, PAWEL WOJCIECH; KIM, JINSOO
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 038398/0380 →
Assignment of Assignor's Interest Apr 27, 2016
From: ASKEW, BEN C.
To: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
Reel/Frame 038398/0420 →
Assignment of Assignor's Interest May 10, 2016
From: ASKEW, BEN C.
To: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
Reel/Frame 038538/0905 →
Assignment of Assignor's Interest May 10, 2016
From: BREAKTHROUGH CHEMISTRY ADVISORS, LLC
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 038538/0977 →
Assignment of Assignor's Interest May 10, 2016
From: ONG, WINSTON ZAPANTA; NOWAK, PAWEL WOJCIECH; KIM, JINSOO
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 038539/0133 →
Assignment of Assignor's Interest May 10, 2016
From: ENLOW, ELIZABETH; NGUYEN, MINH NGOC; ONG, WINSTON Z.
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 038539/0266 →
Assignment of Assignor's Interest May 12, 2017
From: ONG, WINSTON ZAPANTA; NOWAK, PAWEL WOJCIECH; FEUTRILL, JOHN THOMAS; KIM, JINSOO
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 042355/0716 →
Assignment of Assignor's Interest May 24, 2017
From: ENLOW, ELIZABETH; NGUYEN, MINH NGOC; ONG, WINSTON Z.
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 042494/0358 →
Assignment of Assignor's Interest Jun 8, 2017
From: NOWAK, PAWEL WOJCIECH; NGUYEN, MINH NGOC; ENLOW, ELIZABETH; ONG, WINSTON ZAPANTA
To: KALA PHARMACEUTICALS, INC.
Reel/Frame 042655/0637 →